| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9365637 | Human Pathology | 2005 | 10 Pages |
Abstract
In conclusion, morphologic criteria for complete cytogenetic response in patients with CML treated with imatinib can be defined. Persistent high-level morphologic abnormalities herald early on a high likelihood to fail treatment and call for more intense or alternative therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Pathology and Medical Technology
Authors
Alessandro MD, Monika MD, Sergio B. MD, Alois MD, Jakob MD, Urs MD, Wolfgang MD, Hanne MD, Marianne MD, Bettina MD, Sara MD, Silke MD, André MD, Stephan MD,